Keyphrases
Biopharmaceutical Development
11%
Breast Cancer
11%
Cancer Inhibition
11%
Chemical Modification
11%
Controlled Release
100%
Dicer
100%
Dicer Processing
11%
Dwellers
11%
Endosome
11%
FDA-approved Drugs
11%
Intracellular Processing
11%
Molecular Beacon
11%
Mouse Tumor Model
11%
Nanoparticles
100%
Non-small Cell Lung Cancer (NSCLC)
11%
Optimization Modification
11%
Parameter Optimization
11%
Phi29 pRNA
100%
Rational Design
100%
RNA Interference
11%
RNA Therapeutics
11%
Sequence Parameters
11%
Sequence Structure
11%
SiRNA Drugs
11%
SiRNA Nanoparticle
11%
Small Cell Prostate Cancer
11%
Small Interfering RNA (siRNA)
100%
Still Face
11%
Structure Optimization
22%
Survivin
11%
Targeted Delivery
11%
Tumor Cells
22%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
11%
Cancer Inhibition
11%
Controlled Release
100%
Dicer
100%
Diseases
11%
Drug Development
11%
Nanoparticle
100%
Neoplasm
22%
Non Small Cell Lung Cancer
11%
Prostate Cancer
11%
Small Interfering RNA
100%
Survivin
11%
Biochemistry, Genetics and Molecular Biology
Animal Models
16%
Dicer
100%
Drug Development
16%
Gene Inactivation
16%
Molecular Beacon
16%
RNA
33%
RNAI
16%
Small Interfering RNA
100%
Survivin
16%